Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

CPST
Capstone Turbine Corp.
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Dec 2020 29 Sep 2020 29 Jun 2020 30 Mar 2020
Current assets
Cash $31.97 $16.782 $16.229 $15.068
Short term investments
Net receivables $19.079 $13.481 $14.655 $16.24
Inventory $11.224 $13.906 $17.582 $21.46
Total current assets $66.025 $47.832 $53.244 $56.755
Long term investments
Property, plant & equipment $12.905 $13.284 $12.584 $12.867
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $83.799 $65.75 $70.468 $73.955
Current liabilities
Accounts payable $14.527 $10.843 $10.745 $14.9475
Deferred revenue
Short long term debt $0.032 $0.233 $0.431 $0.034
Total current liabilities $23.202 $20.703 $21.634 $26.953
Long term debt $52.929 $30.512 $30.226 $28.096
Total noncurrent liabilities
Total debt
Total liabilities $81.537 $56.902 $57.589 $60.934
Stockholders' equity
Retained earnings -$914.514 -$906.919 -$902.692 -$900.869
Other stockholder equity
Total stockholder equity $2.262 $8.848 $12.879 $13.021
(in millions USD) 2020 2020 2019
Current assets
Cash $15.068 $15.068 $29.727
Short term investments
Net receivables $16.24 $16.24 $16.222
Inventory $22.681 $21.46 $20.343
Total current assets $56.755 $56.755 $70.11
Long term investments
Property, plant & equipment $7.749 $12.867 $5.291
Goodwill & intangible assets
Total noncurrent assets $17.2
Total investments
Total assets $73.955 $73.955 $79.963
Current liabilities
Accounts payable $15 $14.9475 $16.6119
Deferred revenue $8.842
Short long term debt $0.477 $0.034 $0.031
Total current liabilities $26.953 $26.953 $28.087
Long term debt $33.037 $28.096 $27.311
Total noncurrent liabilities $33.981
Total debt $33.514
Total liabilities $60.934 $60.934 $56.809
Stockholders' equity
Retained earnings -$900.869 -$900.869 -$878.884
Other stockholder equity
Total stockholder equity $13.021 $13.021 $23.154

Income statement

XSLX
XSLX
(in millions USD) 30 Dec 2020 29 Sep 2020 29 Jun 2020 30 Mar 2020
Revenue
Total revenue $20.676 $14.906 $14.193 $11.56
Cost of revenue $17.204 $12.344 $10.938 $11.028
Gross profit $3.472 $2.562 $3.255 $0.532
Operating activities
Research & development $0.735 $0.599 $0.37 $0.838
Selling, general & administrative $4.816 $4.872 $3.546 $5.196
Total operating expenses $22.755 $17.815 $14.854 $17.062
Operating income -$2.079 -$2.909 -$0.661 -$5.502
Income from continuing operations
EBIT -$2.079 -$2.909 -$0.661 -$5.502
Income tax expense $0.009 $0.001 $0.004
Interest expense -$1.23 -$1.313 -$1.291 -$1.345
Net income
Net income -$7.595 -$4.212 -$1.823 -$6.95
Income (for common shares) -$7.595 -$4.227 -$1.823 -$6.962
(in millions USD) 2020 2020 2019
Revenue
Total revenue $68.926 $68.926 $83.412
Cost of revenue $59.895 $59.331 $73.182
Gross profit $9.031 $9.595 $10.23
Operating activities
Research & development $3.649 $3.649 $3.6
Selling, general & administrative $22.211 $22.211 $20.958
Total operating expenses $25.86 $85.191 $97.74
Operating income -$16.829 -$16.265 -$14.328
Income from continuing operations
EBIT -$16.688 -$16.265 -$14.328
Income tax expense $0.012 $0.012 $0.008
Interest expense $5.198 -$5.198 -$1.502
Net income
Net income -$21.898 -$21.898 -$16.659
Income (for common shares) -$21.985 -$21.985 -$16.659

Cash flows

XSLX
XSLX
(in millions USD) 30 Dec 2020 29 Sep 2020 29 Jun 2020 30 Mar 2020
Net income -$7.595 -$4.212 -$1.823 -$6.95
Operating activities
Depreciation $0.466 $0.447 $0.448 $0.484
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$3.346 $1.851 -$1.871 -$3.978
Investing activities
Capital expenditures -$0.153 -$1.042 -$0.074 -$0.307
Investments
Total cash flows from investing -$0.153 -$1.042 -$0.074 -$0.307
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $18.677 -$0.233 $1.734 -$0.02
Total cash flows from financing $18.687 -$0.256 $3.106 $2.623
Effect of exchange rate
Change in cash and equivalents $15.188 $0.553 $1.161 -$1.662
(in millions USD) 2020 2020 2019
Net income -$21.898 -$21.898 -$16.659
Operating activities
Depreciation $2.486 $2.486 $1.261
Business acquisitions & disposals
Stock-based compensation $0.913
Total cash flows from operations -$19.698 -$19.698 -$17.703
Investing activities
Capital expenditures -$4.207 -$4.207 -$3.36
Investments
Total cash flows from investing -$4.207 -$4.207 -$3.36
Financing activities
Dividends paid
Sale and purchase of stock $9.959
Net borrowings -$0.613 -$0.613 $20.398
Total cash flows from financing $9.246 $9.246 $31.382
Effect of exchange rate
Change in cash and equivalents -$14.659 -$14.659 $10.319

CXDC
China XD Plastics Co Ltd
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Current assets
Cash $183.334428 $385.205458 $290.796634 $190.433854
Short term investments
Net receivables $424.888337 $149.80276 $184.384982 $240.122877
Inventory $577.935234 $749.370184 $678.543004 $630.11347
Total current assets $1,344.760833 $1,650.722618 $1,559.142766 $1,302.417152
Long term investments $242.100096
Property, plant & equipment $823.700349 $900.677561 $856.884103 $864.316943
Goodwill & intangible assets
Total noncurrent assets $1,579.165167 $1,362.160865 $1,359.670313 $1,366.560004
Total investments $242.100096
Total assets $2,923.926 $3,012.883483 $2,918.813079 $2,668.977156
Current liabilities
Accounts payable $437.356298 $434.660878 $405.187066 $450.011831
Deferred revenue $105.943812 $90.559854 $88.298695 $90.031695
Short long term debt $644.925707 $797.139254 $772.356912 $674.145237
Total current liabilities $1,230.282394 $1,343.19562 $1,282.324759 $1,268.285841
Long term debt $741.385817 $617.109684 $589.702224 $359.492121
Total noncurrent liabilities $926.429369 $792.355393 $759.846945 $587.939108
Total debt $1,386.311524 $1,414.248938 $1,362.059136 $1,033.637358
Total liabilities $2,156.711763 $2,135.551013 $2,042.171704 $1,856.224949
Stockholders' equity
Retained earnings $538.357103 $688.463772 $726.696685 $709.120874
Other stockholder equity -$9.479166 -$47.48972 -$80.085057 -$80.491217
Total stockholder equity $717.189087 $829.285202 $830.734178 $812.752207
(in millions USD) 2020 2019 2018
Current assets
Cash $183.334428 $228.433019 $366.99184
Short term investments
Net receivables $424.888337 $222.072053 $294.688288
Inventory $577.935234 $642.509534 $620.033195
Total current assets $1,344.760833 $1,264.862728 $1,413.931851
Long term investments $242.100096
Property, plant & equipment $823.700349 $874.469671 $775.94128
Goodwill & intangible assets $29.796795
Total noncurrent assets $1,579.165167 $1,371.01952 $1,339.58738
Total investments $242.100096
Total assets $2,923.926 $2,635.882248 $2,753.519231
Current liabilities
Accounts payable $437.356298 $484.381655 $721.49066
Deferred revenue $105.943812 $92.63962 $99.583477
Short long term debt $644.925707 $681.563414 $729.66692
Total current liabilities $1,230.282394 $1,278.954294 $1,594.059845
Long term debt $741.385817 $336.885847 $111.808244
Total noncurrent liabilities $926.429369 $520.553843 $312.965493
Total debt $1,386.311524 $1,018.449261 $841.475164
Total liabilities $2,156.711763 $1,799.508137 $1,907.025338
Stockholders' equity
Retained earnings $538.357103 $720.159368 $717.10389
Other stockholder equity -$9.479166 -$67.907807 -$54.732547
Total stockholder equity $717.189087 $836.374111 $748.917428

Income statement

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Revenue
Total revenue $593.785201 $290.054815 $283.223987 $144.837678
Cost of revenue $529.75849 $255.491692 $243.332297 $139.599821
Gross profit $64.026711 $34.563123 $39.89169 $5.237857
Operating activities
Research & development $8.460952 $4.388573 $5.803128 $3.841792
Selling, general & administrative $12.476666 $11.331492 $3.723179 $6.146037
Total operating expenses $181.934445 $44.31241 $9.526307 $9.987829
Operating income -$117.907734 -$9.749287 $30.365383 -$4.749972
Income from continuing operations
EBIT -$130.554585 -$13.682891 $31.605365 $7.766726
Income tax expense $5.132116 $1.623473 -$1.88499 $0.889031
Interest expense $14.419968 $22.926549 $15.914544 $17.916189
Net income
Net income -$150.106669 -$38.232913 $17.575811 -$11.038494
Income (for common shares) -$150.106669 -$38.232913 $17.575811 -$11.038494
(in millions USD) 2020 2019 2018
Revenue
Total revenue $1,311.901681 $1,448.204826 $1,274.833282
Cost of revenue $1,168.1823 $1,228.809155 $1,055.220493
Gross profit $143.719381 $219.395671 $219.612789
Operating activities
Research & development $22.494445 $50.329809 $60.576574
Selling, general & administrative $33.677374 $36.836142 $47.054671
Total operating expenses $245.760991 $149.977076 $107.631245
Operating income -$102.04161 $69.418595 $111.981544
Income from continuing operations
EBIT -$104.865385 $84.334817 $127.058269
Income tax expense $5.75963 $14.036698 $7.713113
Interest expense $71.17725 $67.242641 $51.031735
Net income
Net income -$181.802265 $3.055478 $68.313421
Income (for common shares) -$181.802265 $3.055478 $68.313421

Cash flows

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Net income -$150.106669 -$38.232913 $17.575811 -$11.038494
Operating activities
Depreciation $62.536351
Business acquisitions & disposals
Stock-based compensation $4.1886
Total cash flows from operations $231.67528 $76.126444 -$221.6622 -$89.161481
Investing activities
Capital expenditures -$184.149287 $4.173357 -$4.672015 -$20.075023
Investments $195.963439 -$72.151747 -$123.811692
Total cash flows from investing -$214.610408 -$67.97839 -$128.483707 -$20.075023
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$22.42758 $0.530865 $326.818383 $27.52158
Total cash flows from financing -$15.31547 $0.887293 $327.586656 $74.143299
Effect of exchange rate -$2.448643 $7.091723 $0.031996 -$2.90596
Change in cash and equivalents -$0.699241 $16.12707 -$22.527255 -$37.999165
(in millions USD) 2020 2019 2018
Net income -$181.802265 $3.055478 $68.313421
Operating activities
Depreciation $62.536351 $60.663133 $46.282307
Business acquisitions & disposals $7.282029 $11.751535
Stock-based compensation $4.1886 $3.353811
Total cash flows from operations -$3.021957 -$189.928239 $61.393255
Investing activities
Capital expenditures -$204.722968 -$138.412642 -$308.256648
Investments $284.547929
Total cash flows from investing -$431.147528 -$130.123203 -$1.675962
Financing activities
Dividends paid
Sale and purchase of stock $0.12
Net borrowings $332.443248 $100.999856 -$20.04643
Total cash flows from financing $387.301778 $185.869389 $2.218817
Effect of exchange rate $1.769116 -$4.376768 -$15.035935
Change in cash and equivalents -$45.098591 -$138.558821 $46.900175

KGJI
Kingold Jewelry Inc
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Sep 2019 30 Jun 2019 31 Mar 2019 31 Dec 2018
Current assets
Cash $15.283597 $129.060883 $16.631506 $5.031576
Short term investments $2,518.397979 $2,215.449367 $2,174.07695 $1,593.557391
Net receivables $0.654455 $0.264158 $0.451059
Inventory $268.2143 $262.76362 $163.848955 $127.034673
Total current assets $3,045.549986 $2,866.554611 $2,632.680342 $1,985.744613
Long term investments $268.85872 $248.69714 $234.08878 $707.992268
Property, plant & equipment $4.420547 $4.924793 $5.104757 $5.39533
Goodwill & intangible assets $0.373324 $0.390837 $0.402673 $0.395719
Total noncurrent assets $274.112115 $254.505407 $240.115505 $714.069085
Total investments $2,787.256699 $2,464.146507 $2,408.16573 $2,301.549659
Total assets $3,319.662101 $3,121.060018 $2,872.795847 $2,699.813698
Current liabilities
Accounts payable $4.410957 $4.383039 $4.164872 $15.749564
Deferred revenue
Short long term debt $1,494.111845 $1,605.122197 $1,674.814595 $1,107.647553
Total current liabilities $1,536.706539 $1,645.465755 $1,712.88968 $1,148.455158
Long term debt $702.335976 $594.448691 $514.976062 $888.804882
Total noncurrent liabilities $829.991281 $666.008897 $527.949779 $913.023793
Total debt $2,196.447821 $2,199.570888 $2,189.790657 $1,996.452435
Total liabilities $2,366.69782 $2,311.474652 $2,240.839459 $2,061.478951
Stockholders' equity
Retained earnings $349.146177 $373.150634 $360.561447 $354.180868
Other stockholder equity $379.386663 $212.070348 $47.030557 $59.794859
Total stockholder equity $952.964281 $809.585366 $631.956388 $638.334747
(in millions USD) 2018 2017 2016
Current assets
Cash $5.031576 $10.531676 $74.11945
Short term investments $1,593.557391 $1,562.943153 $281.895403
Net receivables $0.451059 $0.768167 $0.670878
Inventory $127.034673 $135.042713 $119.435595
Total current assets $1,985.744613 $2,063.119059 $752.985062
Long term investments $707.992268 $964.516988 $1,501.496724
Property, plant & equipment $5.39533 $7.299643 $7.224698
Goodwill & intangible assets $0.395719 $0.429915 $0.413662
Total noncurrent assets $714.069085 $979.226293 $1,509.418087
Total investments $2,301.549659 $2,527.460141 $1,783.392127
Total assets $2,699.813698 $3,042.345352 $2,262.403149
Current liabilities
Accounts payable $15.749564 $21.544164 $20.939793
Deferred revenue
Short long term debt $1,107.647553 $1,269.491393 $263.490196
Total current liabilities $1,148.455158 $1,294.859762 $293.116111
Long term debt $888.804882 $1,357.253203 $1,685.547129
Total noncurrent liabilities $913.023793 $1,357.253203 $1,686.796751
Total debt $1,996.452435 $2,626.744596 $1,949.037325
Total liabilities $2,061.478951 $2,652.112965 $1,979.912862
Stockholders' equity
Retained earnings $354.180868 $304.634154 $278.441502
Other stockholder equity $59.794859 $5.154671 -$76.248201
Total stockholder equity $638.334747 $390.232387 $282.490287

Income statement

XSLX
XSLX
(in millions USD) 30 Sep 2019 30 Jun 2019 31 Mar 2019 31 Dec 2018
Revenue
Total revenue $382.790132 $598.008324 $453.5391 $631.174702
Cost of revenue $367.618629 $528.476748 $398.237634 $556.114612
Gross profit $15.171503 $69.531576 $55.301466 $75.06009
Operating activities
Research & development
Selling, general & administrative $2.265898 $6.733404 $2.618192 $3.96674
Total operating expenses $2.381526 $6.84001 $2.730636 $4.144705
Operating income $12.789977 $62.691566 $52.57083 $70.915385
Income from continuing operations
EBIT $13.061281 $62.990065 $52.909443 $71.293558
Income tax expense -$7.845329 $4.359554 $2.228759 $17.998378
Interest expense $44.911067 $46.041324 $44.300105 $43.794691
Net income
Net income -$24.004457 $12.589187 $6.380579 $9.500489
Income (for common shares) -$24.004457 $12.589187 $6.380579 $9.500489
(in millions USD) 2018 2017 2016
Revenue
Total revenue $2,475.666092 $2,009.732643 $1,420.62497
Cost of revenue $2,211.343314 $1,809.805467 $1,274.250385
Gross profit $264.322778 $199.927176 $146.374585
Operating activities
Research & development
Selling, general & administrative $11.564285 $13.444222 $11.985807
Total operating expenses $12.174007 $13.932721 $12.432182
Operating income $252.148771 $185.994455 $133.942403
Income from continuing operations
EBIT $253.975815 $188.313069 $200.092618
Income tax expense $31.736333 $9.174859 $32.62771
Interest expense $172.692768 $152.945558 $74.555096
Net income
Net income $49.546714 $26.192652 $92.909812
Income (for common shares) $49.546714 $26.192652 $92.909812

Cash flows

XSLX
XSLX
(in millions USD) 30 Sep 2019 30 Jun 2019 31 Mar 2019 31 Dec 2018
Net income -$24.004457 $12.589187 $6.380579 $9.500489
Operating activities
Depreciation $0.330859 $0.172799 $0.487072 $0.509867
Business acquisitions & disposals
Stock-based compensation $0.021456
Total cash flows from operations $62.360833 -$35.543907 -$96.71394 -$95.6813
Investing activities
Capital expenditures -$0.002281 -$0.261484 -$0.0628 $0.345629
Investments -$202.8024
Total cash flows from investing -$202.804681 -$0.261484 -$0.0628 $0.345629
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $77.400335 $57.308486 $143.166041 $83.6223
Total cash flows from financing $79.588793 $57.320517 $140.965552 $78.242126
Effect of exchange rate -$52.988697 $91.001157 -$38.694621 $1.151102
Change in cash and equivalents -$113.843752 $112.516283 $5.494191 -$15.942443
(in millions USD) 2018 2017 2016
Net income $49.546714 $26.192652 $92.909812
Operating activities
Depreciation $1.726916 $1.648938 $1.415067
Business acquisitions & disposals $0.08278
Stock-based compensation $0.021456 $0.033014 $0.044572
Total cash flows from operations $365.670792 -$25.749914 -$74.007221
Investing activities
Capital expenditures -$0.145507 -$1.241172 $150.657383
Investments -$551.95895 -$1,913.618152
Total cash flows from investing -$0.145507 -$553.200122 -$1,762.877989
Financing activities
Dividends paid
Sale and purchase of stock $0.113562
Net borrowings -$355.613839 $519.993493 $1,901.988229
Total cash flows from financing -$367.572979 $560.108415 $1,856.513057
Effect of exchange rate -$3.078755 $2.505553 -$1.395223
Change in cash and equivalents -$5.126449 -$16.336068 $18.232624

ONCS
OncoSec Medical Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Dec 2022 30 Sep 2022 30 Jun 2022 31 Mar 2022
Current assets
Cash $3.68333 $5.729691 $12.29974 $19.477493
Short term investments
Net receivables
Inventory
Total current assets $6.441575 $8.633159 $15.232471 $21.135929
Long term investments
Property, plant & equipment $1.523671 $4.864784 $5.644129 $5.934171
Goodwill & intangible assets $0.343588 $0.361059 $0.378529 $0.396
Total noncurrent assets $2.429567 $5.805803 $6.645897 $6.858261
Total investments
Total assets $8.871142 $14.438962 $21.878368 $27.99419
Current liabilities
Accounts payable $4.690271 $4.802456 $4.208222 $3.145828
Deferred revenue
Short long term debt $1.337653 $1.63844 $2.048129 $1.198195
Total current liabilities $7.231043 $6.909514 $6.633328 $4.686904
Long term debt $2.12656 $3.513897 $4.126636 $4.418671
Total noncurrent liabilities $7.12656 $8.513897 $9.126636 $9.418671
Total debt $3.464213 $5.152337 $6.174765 $5.616866
Total liabilities $14.357603 $15.423411 $15.759964 $14.105575
Stockholders' equity
Retained earnings -$300.879943 -$294.019063 -$285.957665 -$277.741381
Other stockholder equity $0.153684 $0.898906 $0.247211 $0.178731
Total stockholder equity -$5.486461 -$0.984449 $6.118404 $13.888615
(in millions USD) 2022 2021 2020
Current assets
Cash $12.29974 $45.951233 $20.354462
Short term investments
Net receivables
Inventory
Total current assets $15.232471 $49.179424 $22.821685
Long term investments
Property, plant & equipment $5.644129 $6.374565 $6.762718
Goodwill & intangible assets $0.378529 $0.448412
Total noncurrent assets $6.645897 $7.0965 $7.081776
Total investments
Total assets $21.878368 $56.275924 $29.903461
Current liabilities
Accounts payable $4.208222 $5.561645 $7.923036
Deferred revenue
Short long term debt $2.048129 $2.079616 $1.469866
Total current liabilities $6.633328 $7.961916 $9.678029
Long term debt $4.126636 $5.238207 $6.354996
Total noncurrent liabilities $9.126636 $10.238207 $6.354996
Total debt $6.174765 $7.317823 $7.824862
Total liabilities $15.759964 $18.200123 $16.033025
Stockholders' equity
Retained earnings -$285.957665 -$251.778031 -$206.6103
Other stockholder equity $0.247211 -$0.079109 -$0.019504
Total stockholder equity $6.118404 $38.075801 $13.870436

Income statement

XSLX
XSLX
(in millions USD) 31 Dec 2022 30 Sep 2022 30 Jun 2022 31 Mar 2022
Revenue
Total revenue
Cost of revenue
Gross profit
Operating activities
Research & development $4.653595 $4.768372 $5.319626 $7.030607
Selling, general & administrative $3.009912 $2.538497 $2.812797 $2.517105
Total operating expenses $7.678143 $7.268771 $8.130011 $9.54553
Operating income -$7.678143 -$7.268771 -$8.130011 -$9.54553
Income from continuing operations
EBIT -$6.824379 -$8.050317 -$8.211468 -$9.581721
Income tax expense $0.00295 $0.000019 -$3.337117
Interest expense $0.033551 $0.011081 $0.004797 $0.002701
Net income
Net income -$6.86088 -$8.061398 -$8.216284 -$6.247305
Income (for common shares) -$6.86088 -$8.061398 -$8.216284 -$6.247305
(in millions USD) 2022 2021 2020
Revenue
Total revenue
Cost of revenue
Gross profit
Operating activities
Research & development $25.821543 $34.097641 $25.096817
Selling, general & administrative $11.190519 $14.282417 $18.312268
Total operating expenses $37.012062 $48.380058 $43.224033
Operating income -$37.012062 -$48.380058 -$43.224033
Income from continuing operations
EBIT -$37.492857 -$47.564057 -$43.120897
Income tax expense -$3.334148 -$2.412183 -$0.872585
Interest expense $0.020925 $0.015857 $0.005114
Net income
Net income -$34.179634 -$45.167731 -$42.253426
Income (for common shares) -$34.179634 -$45.167731 -$42.253426

Cash flows

XSLX
XSLX
(in millions USD) 31 Dec 2022 30 Sep 2022 30 Jun 2022 31 Mar 2022
Net income -$6.86088 -$8.061398 -$8.216284 -$6.247305
Operating activities
Depreciation $0.010505 $0.313869 $0.307514 $0.303527
Business acquisitions & disposals
Stock-based compensation $0.284216 $0.30703 $0.377413 $0.315699
Total cash flows from operations -$6.61102 -$6.126634 -$6.916159 -$5.340687
Investing activities
Capital expenditures
Investments
Total cash flows from investing
Financing activities
Dividends paid
Sale and purchase of stock $3.499988 $0.000915
Net borrowings $1.606274 -$0.276688 -$0.216182 -$0.372468
Total cash flows from financing $4.499096 -$0.343337 -$0.240296 -$0.372282
Effect of exchange rate $0.077018 -$0.100078 -$0.021298 -$0.040531
Change in cash and equivalents -$2.046361 -$6.570049 -$7.177753 -$5.7535
(in millions USD) 2022 2021 2020
Net income -$34.179634 -$45.167731 -$42.253426
Operating activities
Depreciation $1.066316 $1.078163 $0.990288
Business acquisitions & disposals
Stock-based compensation $1.692186 $5.604568 $4.448478
Total cash flows from operations -$32.138339 -$41.794034 -$33.145364
Investing activities
Capital expenditures -$0.244857 -$0.304603
Investments
Total cash flows from investing -$0.244857 -$0.799603
Financing activities
Dividends paid
Sale and purchase of stock $0.2049 $68.28106 $29.981193
Net borrowings -$1.32556 -$0.619105 $0.8145
Total cash flows from financing -$1.161623 $68.209028 $28.399326
Effect of exchange rate -$0.106674 -$0.01862 -$0.04728
Change in cash and equivalents -$33.651493 $25.596771 -$4.793318

VIVE
Viveve Medical Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $5.907 $9.431 $14.045 $19.162
Short term investments
Net receivables $0.86 $0.801 $0.509 $0.549
Inventory $1.615 $1.599 $1.552 $1.472
Total current assets $9.604 $13.238 $17.499 $22.238
Long term investments $0.455 $0.577
Property, plant & equipment $1.009 $1.114 $1.351 $1.554
Goodwill & intangible assets
Total noncurrent assets $2.55 $2.25 $3.185 $3.675
Total investments $0.455 $0.577
Total assets $12.154 $15.488 $20.684 $25.913
Current liabilities
Accounts payable $1.108 $0.904 $1.602 $1.48
Deferred revenue
Short long term debt $5.628 $5.453 $5.285
Total current liabilities $10.837 $10.012 $10.263 $4.533
Long term debt $5.124
Total noncurrent liabilities $0.133 $0.2 $0.265 $6.314
Total debt $5.628 $5.453 $5.285 $5.124
Total liabilities $10.97 $10.212 $10.528 $10.847
Stockholders' equity
Retained earnings -$258.514 -$253.538 -$247.739 -$241.853
Other stockholder equity
Total stockholder equity $1.184 $5.276 $10.156 $15.066
(in millions USD) 2021 2020 2019
Current assets
Cash $19.162 $6.523 $13.308
Short term investments
Net receivables $0.549 $0.77 $1.573
Inventory $1.472 $3.254 $4.861
Total current assets $22.238 $12.843 $22.189
Long term investments $0.577 $0.833 $1.216
Property, plant & equipment $1.554 $2.759 $3.046
Goodwill & intangible assets
Total noncurrent assets $3.675 $3.787 $4.788
Total investments $0.577 $0.833 $1.216
Total assets $25.913 $16.63 $26.977
Current liabilities
Accounts payable $1.48 $0.881 $1.608
Deferred revenue
Short long term debt $0.918
Total current liabilities $4.533 $4.215 $6.306
Long term debt $5.124 $4.943 $3.983
Total noncurrent liabilities $6.314 $5.441 $4.15
Total debt $5.124 $5.861 $3.983
Total liabilities $10.847 $9.656 $10.456
Stockholders' equity
Retained earnings -$241.853 -$219.826 -$197.911
Other stockholder equity
Total stockholder equity $15.066 $6.974 $16.521

Income statement

XSLX
XSLX
(in millions USD) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Revenue
Total revenue $1.684 $1.795 $1.641 $1.706
Cost of revenue $1.138 $1.501 $1.321 $1.747
Gross profit $0.546 $0.294 $0.32 -$0.041
Operating activities
Research & development $1.8 $1.921 $2.14 $2.861
Selling, general & administrative $3.408 $3.393 $3.653 $3.085
Total operating expenses $5.208 $5.314 $5.793 $5.946
Operating income -$4.662 -$5.02 -$5.473 -$5.987
Income from continuing operations
EBIT -$4.684 -$5.515 -$5.616 -$6.062
Income tax expense
Interest expense $0.292 $0.284 $0.27 $0.266
Net income
Net income -$4.976 -$5.799 -$5.886 -$6.328
Income (for common shares) -$6.323 -$7.104 -$7.152 -$7.556
(in millions USD) 2021 2020 2019
Revenue
Total revenue $6.426 $5.479 $6.567
Cost of revenue $5.806 $5.183 $5.551
Gross profit $0.62 $0.296 $1.016
Operating activities
Research & development $9.665 $5.125 $8.59
Selling, general & administrative $12.508 $13.666 $22.363
Total operating expenses $22.173 $18.791 $31.695
Operating income -$21.553 -$18.495 -$30.679
Income from continuing operations
EBIT -$21.027 -$21.005 -$38.172
Income tax expense
Interest expense $1 $0.91 $4.354
Net income
Net income -$22.027 -$21.915 -$42.526
Income (for common shares) -$26.718 -$26.064 -$42.906

Cash flows

XSLX
XSLX
(in millions USD) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$4.976 -$5.799 -$5.886 -$6.328
Operating activities
Depreciation $0.174 $0.188 $0.204 $0.224
Business acquisitions & disposals
Stock-based compensation $0.868 $0.909 $0.96 $1.014
Total cash flows from operations -$3.35 -$4.568 -$5.087 -$3.227
Investing activities
Capital expenditures -$0.193 -$0.059 -$0.049 -$0.294
Investments
Total cash flows from investing -$0.193 -$0.059 -$0.049 -$0.294
Financing activities
Dividends paid
Sale and purchase of stock $0.019 $0.013 $0.019 $0.017
Net borrowings
Total cash flows from financing $0.019 $0.013 $0.019 $0.018
Effect of exchange rate
Change in cash and equivalents -$3.524 -$4.614 -$5.117 -$3.503
(in millions USD) 2021 2020 2019
Net income -$22.027 -$21.915 -$42.526
Operating activities
Depreciation $1.123 $1.297 $1.182
Business acquisitions & disposals
Stock-based compensation $3.779 $2.651 $2.4
Total cash flows from operations -$12.878 -$15.234 -$31.236
Investing activities
Capital expenditures -$0.456 -$0.781 -$1.087
Investments
Total cash flows from investing -$0.456 -$0.781 -$1.087
Financing activities
Dividends paid
Sale and purchase of stock $26.043 $8.748 $16.324
Net borrowings $1.343 -$0.216
Total cash flows from financing $25.973 $9.23 $16.108
Effect of exchange rate
Change in cash and equivalents $12.639 -$6.785 -$16.215